Nobilis Therapeutics Announces IND Filing for a Phase 2b Clinical...

Nobilis Therapeutics moves to strengthen its breadth of labeled uses, files an IND to initiate a phase 2b panic disorder trial.(PRWeb June 22, 2020)Read the full story at https://www.prweb.com/releases/nobilis_therapeutics_announces_ind_filing_for_a_phase_2b_clinical_trial_of_nbtx_001_drug_device_combination_for_treatment_of_panic_disorder/prweb17207407.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news